Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-008729
Filing Date
2017-03-27
Accepted
2017-03-27 19:25:03
Documents
1
Period of Report
2017-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7285
  Complete submission text file 0000899243-17-008729.txt   8621
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 NEWBURY STREET BOSTON MA 02116
Business Address
Exter Neil (Reporting) CIK: 0001620014 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 17716490